Proton-coupled erythromycin antiport at rat blood-placenta barrier

Yoshimichi Sai, Tomohiro Nishimura, Kaori Ochi, Noriaki Tanaka, Akinori Takagi, Masatoshi Tomi, Noriko Kose, Yasuna Kobayashi, Naoki Miyakoshi, Shinji Kitagaki, Chisato Mukai, Emi Nakashima

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The aim of the present study was to characterize the mechanism of erythromycin transport at the blood-placenta barrier, using TR-TBT 18d-1 cells as a model of rat syncytiotrophoblasts. [14C]Erythromycin was taken up by TR-TBT 18d-1 cells with a Michaelis constant of 466 μM. Although the uptake was not dependent on extracellular Na+ or Cl-, it was increased at weakly alkaline pH. Significant overshoot of [ 14C]erythromycin uptake by placental brush-border membrane vesicles was observed in the presence of an outwardly directed proton gradient. These results indicate that erythromycin is transferred by the H+-coupled transport system in syncytiotrophoblasts. To address the physiological transport of erythromycin in rat placenta, fetal-to-maternal transport clearance was estimated by means of the single placental perfusion technique. Clearance of [14C]erythromycin was higher than that of [14C]inulin, a paracellular pathway marker, and was decreased by the addition of 5 mM erythromycin, indicating that saturable efflux system from fetus to mother is involved. The effect of various transporter inhibitors on [14C] erythromycin efflux from TR-TBT 18d-1 cells was evaluated. cyclosporin A, fumitremorgin C, and probenecid had no effect, whereas ethylisopropylamiloride, a specific inhibitor of Na+/H+ exchangers (NHEs), was significantly inhibitory. These results suggest that erythromycin efflux transport at the rat blood-placenta barrier is mediated by an erythromycin/H+ antiport system, driven by H+ supplied by NHEs.

Original languageEnglish
Pages (from-to)1576-1581
Number of pages6
JournalDrug Metabolism and Disposition
Volume38
Issue number9
DOIs
Publication statusPublished - 2010 Sep

Fingerprint

Ion Transport
Erythromycin
Placenta
Protons
Sodium-Hydrogen Antiporter
Trophoblasts
Probenecid
Inulin
Microvilli
Cyclosporine
Fetus
Perfusion
Mothers
Membranes

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Proton-coupled erythromycin antiport at rat blood-placenta barrier. / Sai, Yoshimichi; Nishimura, Tomohiro; Ochi, Kaori; Tanaka, Noriaki; Takagi, Akinori; Tomi, Masatoshi; Kose, Noriko; Kobayashi, Yasuna; Miyakoshi, Naoki; Kitagaki, Shinji; Mukai, Chisato; Nakashima, Emi.

In: Drug Metabolism and Disposition, Vol. 38, No. 9, 09.2010, p. 1576-1581.

Research output: Contribution to journalArticle

Sai, Y, Nishimura, T, Ochi, K, Tanaka, N, Takagi, A, Tomi, M, Kose, N, Kobayashi, Y, Miyakoshi, N, Kitagaki, S, Mukai, C & Nakashima, E 2010, 'Proton-coupled erythromycin antiport at rat blood-placenta barrier', Drug Metabolism and Disposition, vol. 38, no. 9, pp. 1576-1581. https://doi.org/10.1124/dmd.110.033266
Sai, Yoshimichi ; Nishimura, Tomohiro ; Ochi, Kaori ; Tanaka, Noriaki ; Takagi, Akinori ; Tomi, Masatoshi ; Kose, Noriko ; Kobayashi, Yasuna ; Miyakoshi, Naoki ; Kitagaki, Shinji ; Mukai, Chisato ; Nakashima, Emi. / Proton-coupled erythromycin antiport at rat blood-placenta barrier. In: Drug Metabolism and Disposition. 2010 ; Vol. 38, No. 9. pp. 1576-1581.
@article{b56d81c169154fb0bedb8bcda98e8d2a,
title = "Proton-coupled erythromycin antiport at rat blood-placenta barrier",
abstract = "The aim of the present study was to characterize the mechanism of erythromycin transport at the blood-placenta barrier, using TR-TBT 18d-1 cells as a model of rat syncytiotrophoblasts. [14C]Erythromycin was taken up by TR-TBT 18d-1 cells with a Michaelis constant of 466 μM. Although the uptake was not dependent on extracellular Na+ or Cl-, it was increased at weakly alkaline pH. Significant overshoot of [ 14C]erythromycin uptake by placental brush-border membrane vesicles was observed in the presence of an outwardly directed proton gradient. These results indicate that erythromycin is transferred by the H+-coupled transport system in syncytiotrophoblasts. To address the physiological transport of erythromycin in rat placenta, fetal-to-maternal transport clearance was estimated by means of the single placental perfusion technique. Clearance of [14C]erythromycin was higher than that of [14C]inulin, a paracellular pathway marker, and was decreased by the addition of 5 mM erythromycin, indicating that saturable efflux system from fetus to mother is involved. The effect of various transporter inhibitors on [14C] erythromycin efflux from TR-TBT 18d-1 cells was evaluated. cyclosporin A, fumitremorgin C, and probenecid had no effect, whereas ethylisopropylamiloride, a specific inhibitor of Na+/H+ exchangers (NHEs), was significantly inhibitory. These results suggest that erythromycin efflux transport at the rat blood-placenta barrier is mediated by an erythromycin/H+ antiport system, driven by H+ supplied by NHEs.",
author = "Yoshimichi Sai and Tomohiro Nishimura and Kaori Ochi and Noriaki Tanaka and Akinori Takagi and Masatoshi Tomi and Noriko Kose and Yasuna Kobayashi and Naoki Miyakoshi and Shinji Kitagaki and Chisato Mukai and Emi Nakashima",
year = "2010",
month = "9",
doi = "10.1124/dmd.110.033266",
language = "English",
volume = "38",
pages = "1576--1581",
journal = "Drug Metabolism and Disposition",
issn = "0090-9556",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "9",

}

TY - JOUR

T1 - Proton-coupled erythromycin antiport at rat blood-placenta barrier

AU - Sai, Yoshimichi

AU - Nishimura, Tomohiro

AU - Ochi, Kaori

AU - Tanaka, Noriaki

AU - Takagi, Akinori

AU - Tomi, Masatoshi

AU - Kose, Noriko

AU - Kobayashi, Yasuna

AU - Miyakoshi, Naoki

AU - Kitagaki, Shinji

AU - Mukai, Chisato

AU - Nakashima, Emi

PY - 2010/9

Y1 - 2010/9

N2 - The aim of the present study was to characterize the mechanism of erythromycin transport at the blood-placenta barrier, using TR-TBT 18d-1 cells as a model of rat syncytiotrophoblasts. [14C]Erythromycin was taken up by TR-TBT 18d-1 cells with a Michaelis constant of 466 μM. Although the uptake was not dependent on extracellular Na+ or Cl-, it was increased at weakly alkaline pH. Significant overshoot of [ 14C]erythromycin uptake by placental brush-border membrane vesicles was observed in the presence of an outwardly directed proton gradient. These results indicate that erythromycin is transferred by the H+-coupled transport system in syncytiotrophoblasts. To address the physiological transport of erythromycin in rat placenta, fetal-to-maternal transport clearance was estimated by means of the single placental perfusion technique. Clearance of [14C]erythromycin was higher than that of [14C]inulin, a paracellular pathway marker, and was decreased by the addition of 5 mM erythromycin, indicating that saturable efflux system from fetus to mother is involved. The effect of various transporter inhibitors on [14C] erythromycin efflux from TR-TBT 18d-1 cells was evaluated. cyclosporin A, fumitremorgin C, and probenecid had no effect, whereas ethylisopropylamiloride, a specific inhibitor of Na+/H+ exchangers (NHEs), was significantly inhibitory. These results suggest that erythromycin efflux transport at the rat blood-placenta barrier is mediated by an erythromycin/H+ antiport system, driven by H+ supplied by NHEs.

AB - The aim of the present study was to characterize the mechanism of erythromycin transport at the blood-placenta barrier, using TR-TBT 18d-1 cells as a model of rat syncytiotrophoblasts. [14C]Erythromycin was taken up by TR-TBT 18d-1 cells with a Michaelis constant of 466 μM. Although the uptake was not dependent on extracellular Na+ or Cl-, it was increased at weakly alkaline pH. Significant overshoot of [ 14C]erythromycin uptake by placental brush-border membrane vesicles was observed in the presence of an outwardly directed proton gradient. These results indicate that erythromycin is transferred by the H+-coupled transport system in syncytiotrophoblasts. To address the physiological transport of erythromycin in rat placenta, fetal-to-maternal transport clearance was estimated by means of the single placental perfusion technique. Clearance of [14C]erythromycin was higher than that of [14C]inulin, a paracellular pathway marker, and was decreased by the addition of 5 mM erythromycin, indicating that saturable efflux system from fetus to mother is involved. The effect of various transporter inhibitors on [14C] erythromycin efflux from TR-TBT 18d-1 cells was evaluated. cyclosporin A, fumitremorgin C, and probenecid had no effect, whereas ethylisopropylamiloride, a specific inhibitor of Na+/H+ exchangers (NHEs), was significantly inhibitory. These results suggest that erythromycin efflux transport at the rat blood-placenta barrier is mediated by an erythromycin/H+ antiport system, driven by H+ supplied by NHEs.

UR - http://www.scopus.com/inward/record.url?scp=77955989821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955989821&partnerID=8YFLogxK

U2 - 10.1124/dmd.110.033266

DO - 10.1124/dmd.110.033266

M3 - Article

C2 - 20566696

AN - SCOPUS:77955989821

VL - 38

SP - 1576

EP - 1581

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 0090-9556

IS - 9

ER -